FILTER RESULTS
FILTER RESULTS
close.svg
Search Result for “molnupiravir”

Showing 1 - 6 of 6

OPINION

Herbal marvel needs support

Oped, Editorial, Published on 25/06/2024

» Now that Covid-19 has become endemic, the Public Health Ministry medical guidelines removing green chiretta, or fah talai jone, a traditional herb, from the list of essential medicines for Covid-19 patients has raised eyebrows among those advocating for alternative medicine.

OPINION

Just the tonic for Covid

Oped, Editorial, Published on 28/10/2023

» As the country has overcome the coronavirus crisis, interest in promoting research into green chiretta or fah talai jone, a herbal medicine that played a role in treating a large number of patients at the peak of the pandemic, has subsided. This is unfortunate.

OPINION

Review Covid drug policy

News, Editorial, Published on 21/11/2022

» Covid-19 cases have been surging over the past few weeks including a rise in the number of new cases which is likely to last until early next year.

OPINION

Lift antiviral drug curbs

News, Editorial, Published on 08/08/2022

» With new cases of Covid-19 having risen to more than 28,000 a day, and with soaring severe cases, restricted access to Covid-19 antiviral medicines is now a critical issue.

OPINION

Travel ban is right move

News, Editorial, Published on 29/11/2021

» The government's decision to ban travel to Thailand by people from eight southern African countries where a new Covid-19 strain was found is the right move but many more things are needed to prevent the country from being hit by the new and dangerous variant.

OPINION

Review antiviral plan

News, Editorial, Published on 11/10/2021

» It is a harsh reality that Covid-19 could linger for years with vaccines to tackle it neither highly effective against new variants nor accessible to everyone. The world therefore is throwing its weight behind research and development of antiviral drugs.